1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/31/2023 | NDRA | Buy Now | ENDRA Life Sciences | $1.08 | 733.33% | HC Wainwright & Co. | Vernon Bernardino | $100 → $9 | Reiterates | → Buy | Get Alert |
04/07/2022 | NDRA | Buy Now | ENDRA Life Sciences | $1.08 | 362.96% | HC Wainwright & Co. | Vernon Bernardino | $120 → $100 | Maintains | Buy | Get Alert |
The latest price target for ENDRA Life Sciences (NASDAQ: NDRA) was reported by HC Wainwright & Co. on March 31, 2023. The analyst firm set a price target for $9.00 expecting NDRA to rise to within 12 months (a possible 733.33% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for ENDRA Life Sciences (NASDAQ: NDRA) was provided by HC Wainwright & Co., and ENDRA Life Sciences reiterated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ENDRA Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ENDRA Life Sciences was filed on March 31, 2023 so you should expect the next rating to be made available sometime around March 31, 2024.
While ratings are subjective and will change, the latest ENDRA Life Sciences (NDRA) rating was a reiterated with a price target of $100.00 to $9.00. The current price ENDRA Life Sciences (NDRA) is trading at is $1.08, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.